These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 26382031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S, Haraguchi G, Sasaki A, Arai H, Muto S, Itai A, Doi S, Mizutani S, Isobe M.
    Cardiovasc Res; 2013 Jul 01; 99(1):35-43. PubMed ID: 23631839
    [Abstract] [Full Text] [Related]

  • 3. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
    Deng Y, Guo SL, Li JQ, Xie SS, Zhou YC, Wei B, Wang Q, Wang F.
    Life Sci; 2021 Jan 01; 264():118709. PubMed ID: 33152351
    [Abstract] [Full Text] [Related]

  • 4. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C, Zakrzewicz D, Dahal BK, Bálint Z, Murmann K, Wygrecka M, Seeger W, Schermuly RT, Weissmann N, Kwapiszewska G.
    Thromb Haemost; 2014 Dec 01; 112(6):1288-303. PubMed ID: 25231004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects.
    Kishimoto Y, Kato T, Ito M, Azuma Y, Fukasawa Y, Ohno K, Kojima S.
    J Thorac Cardiovasc Surg; 2015 Sep 01; 150(3):645-54.e3. PubMed ID: 26095621
    [Abstract] [Full Text] [Related]

  • 7. 5-Aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine monophosphate cyclohydrolase promotes pulmonary arterial smooth muscle cell proliferation via the Ras signaling pathway.
    Shi X, Ma Q, Huo Y, Su Y.
    Am J Physiol Cell Physiol; 2024 Oct 01; 327(4):C901-C912. PubMed ID: 39129491
    [Abstract] [Full Text] [Related]

  • 8. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J, Thuillet R, Tu L, Phan C, Cumont A, Marsol C, Huertas A, Savale L, Hibert M, Galzi JL, Bonnet D, Humbert M, Frossard N, Guignabert C.
    Cardiovasc Res; 2020 Mar 01; 116(3):686-697. PubMed ID: 31173066
    [Abstract] [Full Text] [Related]

  • 9. Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells.
    Shan X, Gegentuya, Wang J, Feng H, Zhang Z, Zheng Q, Zhang Q, Yang K, Wang J, Xu L.
    Am J Physiol Cell Physiol; 2023 Oct 01; 325(4):C1058-C1072. PubMed ID: 37661916
    [Abstract] [Full Text] [Related]

  • 10. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
    Yamamura A, Fujiwara M, Kawade A, Amano T, Hossain A, Nayeem MJ, Kondo R, Suzuki Y, Inoue Y, Hayashi H, Suzuki S, Sato M, Yamamura H.
    Eur J Pharmacol; 2024 Jun 15; 973():176564. PubMed ID: 38614383
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R, Wei Z, Zhu D, Fu N, Wang C, Yin S, Liang Y, Xing J, Wang X, Wang Y.
    Pulm Pharmacol Ther; 2018 Feb 15; 48():124-135. PubMed ID: 29133079
    [Abstract] [Full Text] [Related]

  • 15. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G, Wang X, Li Y, He L.
    Stem Cell Res Ther; 2017 Feb 10; 8(1):34. PubMed ID: 28187784
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats.
    Zhai FG, Zhang XH, Wang HL.
    Clin Exp Pharmacol Physiol; 2009 Aug 10; 36(8):850-6. PubMed ID: 19298536
    [Abstract] [Full Text] [Related]

  • 17. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L, Wang Y, Wu G, Rao L, Wei Y, Yue H, Yuan T, Yang P, Xiong F, Zhang S, Zhou Q, Chen Z, Li J, Mo BW, Zhang H, Xiong W, Wang CY.
    Cell Prolif; 2020 Feb 10; 53(2):e12742. PubMed ID: 31943454
    [Abstract] [Full Text] [Related]

  • 18. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Yang J, Li X, Al-Lamki RS, Wu C, Weiss A, Berk J, Schermuly RT, Morrell NW.
    Arterioscler Thromb Vasc Biol; 2013 Jan 10; 33(1):34-42. PubMed ID: 23139294
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X, Chen Y, Tan J, Dai Y, Mao W, Qin G, Ye S, Sun J, Yang Z, Chen J.
    Vascul Pharmacol; 2019 May 10; 116():24-35. PubMed ID: 28694128
    [Abstract] [Full Text] [Related]

  • 20. β-catenin mediates monocrotaline-induced pulmonary hypertension via glycolysis in rats.
    Meng H, Deng Y, Liao J, Wu DD, Li LX, Chen X, Lan WF.
    BMC Cardiovasc Disord; 2024 Jul 23; 24(1):381. PubMed ID: 39044140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.